Shared-care survivorship program for testicular cancer patients: safe and feasible

被引:4
作者
Boery, H. [1 ]
Lubberts, S. [1 ]
Bunskoek, S. [1 ]
Nuver, J. [1 ]
Lefrandt, J. D. [2 ]
Steursma, G. [1 ]
Sluiter, W. J. [3 ]
Siesling, S. [4 ,5 ]
Berendsen, A. J. [6 ]
Gietema, J. A. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Vasc Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
[4] Netherlands Comprehens Canc Org, Dept Res & Dev, Utrecht, Netherlands
[5] Univ Twente, Dept Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands
关键词
testicular cancer; cancer survivorship; TERM-FOLLOW-UP; LONG-TERM; CARDIOVASCULAR-DISEASE; HOSPITAL ANXIETY; RISK; VALIDITY;
D O I
10.1016/j.esmoop.2022.100488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Testicular cancer survivors are at risk for cardiovascular disease, often preceded by early development of cardiovascular risk factors due to chemotherapeutic treatment. Therefore, close collaboration between oncologists and primary care physicians (PCPs) is needed during follow-up to monitor and manage cardiovascular risk factors. We designed a shared-care survivorship program, in which testicular cancer patients visit both their oncologist and their PCP. The objective of this study was to test the safety and feasibility of shared-care follow-up after treatment for metastatic testicular cancer. Patients and methods: The study was designed as an observational cohort study with a stopping rule to check for the safety of follow-up. Safety boundaries were defined for failures in the detection of signals indicating cancer recurrence. Secondary outcomes were the proportion of carried out cardiovascular risk assessments, psychosocial status and patient preferences measured with an evaluation questionnaire. Results: One hundred and sixty-two patients were enrolled (69% of eligible testicular cancer patients). Almost all (99%, n = 150) PCPs of the enrolled patients agreed to participate in the study. In total, 364 primary care visits took place. No failures occurred in the detection of relapsed testicular cancer. Four follow-up visits were considered as failures because of organizational issues, without activation of the stopping rule. Eventually, the safe boundary was crossed indicating that this shared-care model is a safe alternative for follow-up after testicular cancer. Patients were satisfied with the knowledge level of PCPs. PCPs were willing to further extend their role in follow-up care after cancer. Conclusions: Shared-care follow-up is safe and feasible in this patient population. Patients benefit from personalized care, partly close to their home. Within shared care, PCPs can have an important role in cardiovascular risk management and psychosocial survivorship issues.
引用
收藏
页数:7
相关论文
共 20 条
[11]   Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up [J].
Haugnes, Hege S. ;
Bosl, George J. ;
Boer, Hink ;
Gietema, Jourik A. ;
Brydoy, Marianne ;
Oldenburg, Jan ;
Dahl, Alv A. ;
Bremnes, Roy M. ;
Fossa, Sophie D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30) :3752-3763
[12]   Systematic Review of the Impact of Cancer Survivorship Care Plans on Health Outcomes and Health Care Delivery [J].
Jacobsen, Paul B. ;
DeRosa, Antonio P. ;
Henderson, Tara O. ;
Mayer, Deborah K. ;
Moskowitz, Chaya S. ;
Paskett, Electra D. ;
Rowland, Julia H. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) :2088-+
[13]   American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care [J].
McCabe, Mary S. ;
Bhatia, Smita ;
Oeffinger, Kevin C. ;
Reaman, Gregory H. ;
Tyne, Courtney ;
Wollins, Dana S. ;
Hudson, Melissa M. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) :631-640
[14]   THE MOS 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) .2. PSYCHOMETRIC AND CLINICAL-TESTS OF VALIDITY IN MEASURING PHYSICAL AND MENTAL-HEALTH CONSTRUCTS [J].
MCHORNEY, CA ;
WARE, JE ;
RACZEK, AE .
MEDICAL CARE, 1993, 31 (03) :247-263
[15]  
NHG, 2012, HUISARTS WET, V55, P14
[16]   Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Oldenburg, J. ;
Fossa, S. D. ;
Nuver, J. ;
Heidenreich, A. ;
Schmoll, H-J ;
Bokemeyer, C. ;
Horwich, A. ;
Beyer, J. ;
Kataja, V. .
ANNALS OF ONCOLOGY, 2013, 24 :125-132
[17]   The expanding role of primary care in cancer control [J].
Rubin, Greg ;
Berendsen, Annette ;
Crawford, S. Michael ;
Dommett, Rachel ;
Earle, Craig ;
Emery, Jon ;
Fahey, Tom ;
Grassi, Luigi ;
Grunfeld, Eva ;
Gupta, Sumit ;
Hamilton, Willie ;
Hiom, Sara ;
Hunter, David ;
Lyratzopoulos, Georgios ;
Macleod, Una ;
Mason, Robert ;
Mitchell, Geoffrey ;
Neal, Richard D. ;
Peake, Michael ;
Roland, Martin ;
Seifert, Bohumil ;
Sisler, Jeff ;
Sussman, Jonathan ;
Taplin, Stephen ;
Vedsted, Peter ;
Voruganti, Teja ;
Walter, Fiona ;
Wardle, Jane ;
Watson, Eila ;
Weller, David ;
Wender, Richard ;
Whelan, Jeremy ;
Whitlock, James ;
Wilkinson, Clare ;
de Wit, Niek ;
Zimmermann, Camilla .
LANCET ONCOLOGY, 2015, 16 (12) :1231-1272
[18]   Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer [J].
van den Belt-Dusebout, AW ;
Nuver, J ;
de Wit, R ;
Gietema, JA ;
Huinink, WWT ;
Rodrigus, PTR ;
Schimmel, EC ;
Aleman, BMP ;
van Leeuwen, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :467-475
[19]   Sentinel node dissection is safe in the treatment of early-stage vulvar cancer [J].
Van der Zee, Ate G. J. ;
Oonk, Maaike H. ;
De Hullu, Joanne A. ;
Ansink, Anca C. ;
Vergote, Ignace ;
Verheijen, Rene H. ;
Maggioni, Angelo ;
Gaarenstroom, Katja N. ;
Baldwin, Peter J. ;
Van Dorst, Eleonore B. ;
Van der Velden, Jacobus ;
Hermans, Ralph H. ;
van der Putten, Hans ;
Drouin, Pierre ;
Schneider, Achim ;
Sluiter, Wim J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :884-889
[20]   THE HOSPITAL ANXIETY AND DEPRESSION SCALE [J].
ZIGMOND, AS ;
SNAITH, RP .
ACTA PSYCHIATRICA SCANDINAVICA, 1983, 67 (06) :361-370